About Brixy Pharmaceuticals
Brixy Pharmaceuticals is a Healthcare company based in Hyderabad (India) founded in 2018. Manufacturer of generic drugs. It operates on a Traditional Pharmaceuticals model. Its Indian entity Brixy Pharmaceuticals Private Limited reported revenue of βΉ30.7 Lakh. Brixy Pharmaceuticals offers products and services including Brixy Pharmaceuticals Platform. Its focus areas include Traditional Pharmaceuticals, Generics, Companies and Diversified.
Company details
Brixy Pharmaceuticals, established in 2018, excels in providing healthcare solutions, traditional pharmaceuticals, traditional pharmaceuticals, and providing healthcare solutions. Manufacturer of generic drugs. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Hyderabad, India
- SectorsHealthcare
- Website brixypharma.com
- Legal Name Brixy Pharmaceuticals Pvt Ltd
- Date of Incorporation 09 Jan, 2018
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹30.7 Lakh
FY 2019
- Net Profit₹28,636
FY 2019 · 1% margin
- EBITDA₹93,822
FY 2019 · 3% margin
Associated legal entities of Brixy Pharmaceuticals
Brixy Pharmaceuticals operates through Brixy Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2019) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Brixy Pharmaceuticals Private Limited CIN U24110TG2018PTC121728 | Active | 09 Jan 2018 | Hyderabad, Telangana | ₹0.3 Cr | 2 | View details |
Products & Services of Brixy Pharmaceuticals
Brixy Pharmaceuticals offers a comprehensive portfolio of products and services, including Brixy Pharmaceuticals Platform.
Manufacturer of generic drugs
Board of directors of Brixy Pharmaceuticals Private Limited (Brixy Pharmaceuticals)
Brixy Pharmaceuticals Private Limited is the primary company behind Brixy Pharmaceuticals. The board of Brixy Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Lavanya Kondabathula, appointed in 2018.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Lavanya Kondabathula DIN 08032970 | Director | 09 Jan 2018 | 8 yrs 10 mo | Brixy Pharmaceuticals Private Limited |
| Sridhar Kondabathula DIN 08032961 | Director | 09 Jan 2018 | 8 yrs 10 mo | Brixy Pharmaceuticals Private Limited |
Financials of Brixy Pharmaceuticals
Figures of Brixy Pharmaceuticals Private Limited, the primary company behind Brixy Pharmaceuticals, for FY 2019. Revenue was ₹30.7 Lakh. Net profit was ₹28,636 (1% margin). EBITDA was ₹93,822 (3% margin).
- ₹30.7 LakhRevenue · FY 2019
- ₹28,636Net profit · 1% margin
- ₹93,822EBITDA · 3% margin
- ₹1 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Brixy Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Brixy Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Brixy Pharmaceuticals
Brixy Pharmaceuticals was founded in 2018.
Brixy Pharmaceuticals is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
The primary company behind Brixy Pharmaceuticals, Brixy Pharmaceuticals Private Limited, reported revenue of βΉ30.7 Lakh for FY 2019.
Brixy Pharmaceuticals, established in 2018, excels in providing healthcare solutions, traditional pharmaceuticals, traditional pharmaceuticals, and providing healthcare solutions. Manufacturer of generic drugs. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide. It continues to evolve, meeting industry challenges with strategic approaches.
Brixy Pharmaceuticals offers Brixy Pharmaceuticals Platform.
Brixy Pharmaceuticals operates through Brixy Pharmaceuticals Private Limited.
The legal entities of Brixy Pharmaceuticals currently have 2 directors, including Lavanya Kondabathula, Sridhar Kondabathula.
